Evidence map›Paper›PMID 36060092›Full record

ArticleSTAR protocols2022

Generation of dual-gRNA library for combinatorial CRISPR screening of synthetic lethal gene pairs.

Shan Tang, Xue Wu, Jinghui Liu, Qiongsi Zhang, Xinyi Wang, Shuai Shao, Birkan Gokbag, Kunjie Fan, Xiaoqi Liu, Fuhai Li and 2 more

Open access · goldAbstract read
In one paragraph

Article in STAR protocols, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. SLKB: synthetic lethality knowledge base.Nucleic acids research · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Shan TangCollege of Pharmacy, The Ohio State University, Columbus, OH 43210, USA. Electronic address: shan.tang@osumc.edu.
Xue WuDepartment of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
Jinghui LiuDepartment of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY 40536, USA.
Qiongsi ZhangDepartment of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY 40536, USA.
Xinyi WangDepartment of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY 40536, USA.
Shuai ShaoCollege of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.
Birkan GokbagDepartment of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
Kunjie FanDepartment of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
Xiaoqi LiuDepartment of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY 40536, USA.
Fuhai LiInstitute for Informatics and Department of Pediatrics, Washington University in St. Louis, St. Louis, MO 63110, USA.
Lijun ChengDepartment of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
Lang LiDepartment of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, OH 43210, USA. Electronic address: lang.li@osumc.edu.
The Ohio State University · USUniversity of Kentucky · USWashington University in St. Louis · US

Funding

Plk1 in Chemo-resistance of CancerR01CA157429 · NCI · UNIVERSITY OF KENTUCKY · PI XIAOQI LIU · 2011 to 2026
$3.5M
Improving chemotherapy of castration-resistant prostate cancer.R01CA196634 · NCI · UNIVERSITY OF KENTUCKY · PI LIU, XIAOQI · 2016 to 2025
$3.3M
Plk1 as a prognostic biomarker for prostate cancerR01CA264652 · NCI · UNIVERSITY OF KENTUCKY · PI LIU, XIAOQI · 2021 to 2025
$2.7M
Enhancing the efficacy of androgen signaling inhibitors in prostate cancerR01CA256893 · NCI · UNIVERSITY OF KENTUCKY · PI LIU, XIAOQI · 2021 to 2025
$2.4M
NCI NIH HHS R01 CA157429NCI NIH HHS R01 CA196634NCI NIH HHS R01 CA256893NCI NIH HHS R01 CA264652
6 · The paper itself

Abstract

Combinatorial CRISPR screening is useful for investigating synthetic lethality (SL) gene pairs. Here, we detail the steps for dual-gRNA library construction, with the introduction of two backbones, LentiGuide_DKO and LentiCRISPR_DKO. We describe steps for

Indexed as

CRISPR-Cas SystemsRNA, Guide, CRISPR-Cas SystemsGene LibraryGenes, LethalSynthetic Lethal MutationsRNA, Guide, CRISPR-Cas SystemsBiotechnology and bioengineeringCRISPRHigh Throughput ScreeningMolecular Biology

Identifiers

PMID36060092
PMCPMC9428847
OpenAlexW4293280550

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.